NCT05497479View on ClinicalTrials.gov

Study Evaluating Techniques for Measuring Tear Production

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Dry Eye Disease
Interventions
DRUG

0.003% AR-15512 to be administered in both eyes

Two rounds of Schirmer tests, performed without anesthetic (per randomization), before and after instillation of 0.003% AR-15512

DRUG

Vehicle to be administered in both eyes

Two rounds of Schirmer tests, performed without anesthetic, before and after instillation of Vehicle

DRUG

0.003% AR-15512 to be administered in both eyes

Two rounds of Schirmer tests, performed with anesthetic (per randomization), before and after instillation of 0.003% AR-15512

DRUG

Vehicle to be administered in both eyes

Two rounds of Schirmer tests, performed with anesthetic (per randomization), before and after instillation of Vehicle

Trial Locations (1)

92663

Eye Research Foundation, Newport Beach

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT05497479 - Study Evaluating Techniques for Measuring Tear Production | Biotech Hunter | Biotech Hunter